Press releases
IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 'MONTPARK' Clinical Trial
8 Apr 24
Press Releases
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
5 Apr 24
Health Care, Press Releases
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
21 Mar 24
Earnings, News, Press Releases
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
14 Mar 24
News, Press Releases
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
11 Mar 24
News, Financing, Markets, Press Releases
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx's VetaFilm® Platform
5 Feb 24
Press Releases, General